Foot-and-Mouth Disease Virus Lacking the Leader Protein and Containing Two Negative DIVA Markers (FMDV LL3B3D A<sub>24</sub>) Is Highly Attenuated in Pigs
Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recomb...
Prif Awduron: | Michael Eschbaumer, Veronika Dill, Jolene C. Carlson, Jonathan Arzt, Carolina Stenfeldt, Peter W. Krug, John M. Hardham, Jacob E. Stegner, Luis L. Rodriguez, Elizabeth Rieder |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
MDPI AG
2020-02-01
|
Cyfres: | Pathogens |
Pynciau: | |
Mynediad Ar-lein: | https://www.mdpi.com/2076-0817/9/2/129 |
Eitemau Tebyg
-
Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency
gan: John M. Hardham, et al.
Cyhoeddwyd: (2020-09-01) -
Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR
gan: Muneeswaran Selvaraj, et al.
Cyhoeddwyd: (2021-11-01) -
The Safety and Efficacy of New DIVA Inactivated Vaccines Against Lumpy Skin Disease in Calves
gan: Gaetano Federico Ronchi, et al.
Cyhoeddwyd: (2024-11-01) -
Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
gan: Tinka Jelsma, et al.
Cyhoeddwyd: (2021-05-01) -
Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins
gan: Anne Balkema-Buschmann, et al.
Cyhoeddwyd: (2022-05-01)